Pub. Date : 2017 May
PMID : 28764868
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | As a use case, we compare the efficacy of lanthionine synthetase C-like 2 (LANCL2), a novel immunoregulatory target with promising efficacy in inflammatory bowel disease (IBD), activation with antibiotics, fecal microbiome transplantation and anti-toxin antibodies in the treatment of CDAD. | cdad | LanC (bacterial lantibiotic synthetase component C)-like 2 | Mus musculus |